Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3171-3184
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3171
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3171
Survival | HR | 95%CI | P value | |
Adjuvant chemotherapy | No | |||
Yes | 0.43 | 0.16-1.18 | 0.10 | |
Number of metastatic lesions | 1 | |||
≥ 2 | 1.95 | 0.64-5.93 | 0.24 | |
Prior extra-thoracic metastasis | No | |||
Yes | 4.97 | 1.03-24.08 | 0.046 | |
Bilateral pulmonary nodules | No | |||
Yes | 1.84 | 0.36-9.43 | 0.47 | |
CEA | ≤ 5 ng/mL | |||
> 5 ng/mL | 2.00 | 0.76-5.28 | 0.16 | |
Type of resection | Lobectomy | |||
Sublobar resection | 0.53 | 0.21-1.35 | 0.19 |
- Citation: Gao Z, Wu SK, Zhang SJ, Wang X, Wu YC, Jin X. Adjuvant chemotherapy for isolated resectable colorectal lung metastasis: A retrospective study using inverse probability treatment weighting propensity analysis. World J Gastrointest Surg 2024; 16(10): 3171-3184
- URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3171.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3171